Markus Sieger - Jan 28, 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role: Director
Signature: /s/ Markus Sieger
Stock symbol: CYTH
Transactions as of: Jan 28, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/1/2022, 08:23 AM
Previous filing: Aug 30, 2021
Next filing: Mar 30, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTH	Common Stock	Award	$0	+4.08K	+6.03%	$0.00	71.7K	Jan 28, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2021. The number of shares received in lieu of cash was calculated based on the closing price of 3.62 per share of common stock on January 28, 2022.

Content

Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2021. The number of shares received in lieu of cash was calculated based on the closing price of 3.62 per share of common stock on January 28, 2022.